TaƱan, Bernardo .
HRN: 18-88-30 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/11/2024
06/17/2024
IVTT
2.25 G
Q12
Sepsis (renal Dose)
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes